2-218357133-T-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_198559.2(CATIP):c.64T>A(p.Cys22Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000174 in 1,613,688 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_198559.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CATIP | NM_198559.2 | c.64T>A | p.Cys22Ser | missense_variant | 2/10 | ENST00000289388.4 | NP_940961.1 | |
CATIP-AS2 | NR_125777.1 | n.53+781A>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CATIP | ENST00000289388.4 | c.64T>A | p.Cys22Ser | missense_variant | 2/10 | 1 | NM_198559.2 | ENSP00000289388 | P1 | |
CATIP-AS2 | ENST00000411433.1 | n.53+781A>T | intron_variant, non_coding_transcript_variant | 3 | ||||||
CATIP | ENST00000480532.1 | n.86T>A | non_coding_transcript_exon_variant | 2/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000790 AC: 12AN: 151914Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251116Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135720
GnomAD4 exome AF: 0.0000109 AC: 16AN: 1461774Hom.: 0 Cov.: 32 AF XY: 0.0000110 AC XY: 8AN XY: 727180
GnomAD4 genome AF: 0.0000790 AC: 12AN: 151914Hom.: 0 Cov.: 31 AF XY: 0.0000944 AC XY: 7AN XY: 74160
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at